Milestone Update
Rockeby is at the threshold of increasing market penetration for our core products that will
deliver sales and revenues and create effi ciencies of scale. Marketing infrastructure is being
established, key personnel appointed and steps to improve the financial standing of the
Company are in motion.
Corporate Update
Fundraising
During the year, the following fundraising activities took place
- Completion of a non-renounceable rights issue for the issue of 123,374,133 shares at 1
cent each to raise $1,233,741 before costs - A placement to sophisticated investors of 45,000,000 shares at 3.5 cents each to raise
$1,575,000 before costs - A non renounceable rights issue for the issue of 63,347,171 listed options at 1 cent each
pursuant to a prospectus dated 30 March 2006. - At the time of writing the Annual Report Rockeby completed a private placement and is
in the midst of a Shareholder Share Purchase Plan (‘SPP”). The private placement was
to sophisticated investors raising $750,000. Under the SPP Rockeby will raise up to
$1,711,496. Funds will be utilised for working capital and marketing.
Avian infl uenza - Fact sheet (reference WHO¹ Feb 2006)
Rockeby has recently moved into Avian Flu Diagnostics. The following section will provide an
understanding of the current background to Avian Infl uenza, and the important economic role
of the poultry industry in Asia.
¹ http://www.who.int/mediacentre/ factheets/avian_infl uenza/en/index.html
